ArticleMolecular therapy : the journal of the American Society of Gene Therapy2012

Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase.

Anton Neschadim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.